Quidel Receives NIH Funding to Accelerate Capacity Expansion for Manufacturing Sofia SARS-CoV-2 Antigen Detection Test
Quidel Corporation (San Diego, CA, USA) has entered into a preliminary letter contract with the National Institutes of Health (NIH) to support the expansion of its manufacturing capacity in San Diego for its diagnostic assays that test for SARS-CoV-2 Antigen using its Sofia Fluorescence Immunoassay (FIA) platform. More...05 Aug 2020
Mammoth Biosciences’ CRISPR SARS-CoV-2 Diagnostic Platform Becomes First CRISPR-Based Initiative to Be Funded by NIH
Mammoth Biosciences (San Francisco, CA, USA) has received a contract from the National Institutes of Health (NIH) as part of its USD 1.5 billion Rapid Acceleration of Diagnostics (RADx) program, making it the first CRISPR based initiative to be funded by the program. More...05 Aug 2020
Rapid COVID-19 Test Uses Graphene-Enhanced Sensor to Produce Signal After Positively Identifying Viral Antigens
A new COVID-19 rapid test delivers accurate and reliable results in seconds using a graphene-enhanced sensor that produces a signal when exposed to COVID-19 viral antigens. More...04 Aug 2020
Elevated Angiotensin 1–7/Angiotensin II Ratio Predicts Favorable Outcomes in Patients with Heart Failure with Potential Link to COVID-19 Patients
A high ratio of angiotensin 1-7 to angiotensin II (Ang 1–7/Ang II ratio), was found to be an independent and incremental predictor of beneficial outcomes, higher survival rate, and decreased hospitalization duration for patients with heart failure and possibly in patients with cardiovascular complications due to COVID-19. More...04 Aug 2020
Applied DNA’s COVID-19 Diagnostic Kit Granted FDA EUA Amendment for Use on Widely Installed RT-PCR Device and High-Throughput RNA Extraction Robotics
Applied DNA Sciences Inc. (Stony Brook, NY, USA) has been granted Emergency Use Authorization (EUA) amendment by the US Food and Drug Administration (FDA) that expands the installed base of PCR equipment platforms which can process the company’s Linea COVID-19 Assay Kit and introduces automation to significantly increase the throughput of the assay by use of robotic RNA extraction. More...03 Aug 2020
New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
New
Tabletop Centrifuge
Mikro 185
 Real Time PCR Kit.jpg)
New
Herpes Virus Test
Human Herpes Virus (HHV-6) Real Time PCR Kit
In Other News
Researchers Develop Cheaper, Rapid, and Accurate Pooling Strategy for RT-PCR-Based Detection of SARS-CoV-2
Diazyme Partners with Maccura Biotechnology to Launch FDA EUA Approved SARS-CoV-2 RT-PCR Diagnostics Test
US FDA Authorizes First Tests from Siemens That Estimate Antibodies from Past COVID-19 Infections
New Rapid Test Determines Amount of Neutralizing Antibodies Against SARS-CoV-2 Within Short Period of Time
US COVID-19 Testing Supply Data Reveal One Million Tests Being Shipped Per Day
Carolina Liquid Chemistries Secures FDA Emergency Use Authorization for COVID-19 Test Kits
Seegene Allplex 2019-nCoV Assay (SARS-CoV-2) Granted Expanded FDA Emergency Use Authorization
Sorrento Therapeutics to Market Columbia University’s Rapid On-Site Detection Test for SARS-CoV-2 Virus in Saliva
AACC Survey Finds Nearly Half of All US Labs Still Do Not Have Supplies for Running COVID-19 Tests
Truvian Sciences’ Easy Check COVID-19 IgM/IgG Test Receives FDA Emergency Use Authorization
Ultrasensitive Droplet Biosensing Method Dramatically Shortens Identification Time for COVID-19
First-of-Its-Kind Rapid COVID-19 Test Detects Neutralizing Antibodies with 99-100% Specificity and 95-100% Sensitivity Within an Hour
Bruker Launches Second-Generation FluoroType SARS-CoV-2 Plus PCR Test
Roche to Launch New SARS-CoV-2 Tests and Begin Conducting Research on Potential COVID-19 Drug
Sputum Testing Has Significantly Higher COVID-19 Detection Rate than Oropharyngeal Swab Testing
US National COVID-19 Diagnostic Supply Registry Launched to Provide Updates on Molecular, Antigen and Serology Tests Shipments
HHS National COVID-19 Testing Implementation Forum to Improve Collaboration in Advancement of Innovation in SARS-CoV-2 Testing
Global COVID-19 Diagnostics and Therapy Market Projected to Reach USD 13.9 Billion in 2025
PerkinElmer Launches New Dried Blood Spot Based COVID-19 Serology Test
COVID-19 Patients with Lymphocytopenia Are Likely to Suffer Severe Disease Symptoms
Quidel’s Sofia SARS Antigen FIA Updates EUA Performance Data to 96.7% PPA Versus PCR
Luminex COVID-19 Antibody Test Receives FDA Emergency Use Authorization
Study Finds Significant Variability in Accuracy of Marketed COVID-19 Antibody Tests
